EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muller, G.
Right arrow Articles by Morawietz, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muller, G.
Right arrow Articles by Morawietz, H.
Experimental Biology and Medicine 231:766-771 (2006)
© 2006 Society for Experimental Biology and Medicine


VASCULAR AND HYPERTENSION

Upregulation of Endothelin Receptor B in Human Endothelial Cells by Low-Density Lipoproteins

Gregor Muller*, Rusan A. Catar*, Bernd Niemann{dagger}, Matthias Barton{ddagger}, Lilla Knels§, Martina Wendel§ and Henning Morawietz*,1

* Department of Vascular Endothelium and Microcirculation, University of Technology Dresden, D-01307 Dresden, Germany; {dagger} Institute of Pathophysiology and Department of Cardiothoracic Surgery, Martin Luther University Halle-Wittenberg, D-06097 Halle, Germany; {ddagger} Medical Policlinic, Department of Medicine, University Hospital, CH-8091 Zürich, Switzerland; and § Department of Anesthesiology and Intensive Care Medicine, University of Technology Dresden, D-01307 Dresden, Germany

To whom requests for reprints should be addressed at 1 Department of Vascular Endothelium and Microcirculation, Medical Faculty Carl Gustav Carus, University of Technology Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany. E-mail: Henning.Morawietz{at}tu-dresden.de

Abstract

Low-density lipoproteins (LDLs) represent the most important treatable risk factors for coronary artery disease. Although it has been previously shown that hypercholesterolemia stimulates the endothelin system, the effects of increased levels of LDL on endothelial endothelin receptors have not been previously studied. In particular, the influence of native and oxidatively modified LDLs (nLDLs and oxLDLs) and the regulatory mechanisms in endothelial cells are currently unknown. Human endothelial cells almost exclusively express the endothelin receptor type B (ETB). Therefore, the effect of nLDL and oxLDL on the expression of ETB was studied in primary cultures of human umbilical vein endothelial cells (HUVEC). HUVEC were stimulated by nLDL and oxLDL in a time-dependent (1–12 hrs) and dose-dependent (25–100 µg/ml) manner. To analyze signal transduction pathways involved in the regulation of ETB, protein kinase C (PKC) was inhibited using 100 nM Ro-31-8220. The mRNA expression of ETB was determined by quantitative reverse transcription–polymerase chain reaction and ETB protein expression by Western blot. Native LDL induced ETB mRNA after 1 hr (100 µg/ml, 199 ± 35%, n = 15, P < 0.05 vs. control). Stimulation of HUVEC with oxLDL increased ETB mRNA expression (1 hr, 100 µg/ml oxLDL: 308 ± 48%, n = 15, P < 0.05 vs. control) as well. Induction of ETB was also found on the protein level. nLDL was even more potent than oxLDL in inducing ETB protein expression. Induction of ETB expression by oxLDL is mediated by PKC. These data demonstrate that low-density lipoproteins even independent of oxidative modification are potent inducers of ETB receptors at the mRNA and protein level in HUVEC. Given the nitric oxide-releasing capacity of endothelial ETB receptors, this effect may represent a possible vasoprotective mechanism.

Key Words: endothelin-1 • endothelin receptor B • endothelium • low-density lipoprotein







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Experimental Biology and Medicine.